West Pharmaceutical Services, Inc. (WST)
396.49
-0.20
(-0.05%)
USD |
NYSE |
Nov 20, 10:20
West Pharmaceutical Services Cash from Operations (Quarterly) : 189.50M for Sept. 30, 2026
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 189.50M |
| June 30, 2026 | 124.00M |
| March 31, 2026 | 89.90M |
| December 31, 2025 | 251.10M |
| September 30, 2025 | 197.20M |
| June 30, 2025 | 177.10M |
| March 31, 2025 | 129.40M |
| December 31, 2024 | 190.10M |
| September 30, 2024 | 180.10M |
| June 30, 2024 | 165.00M |
| March 31, 2024 | 118.20M |
| December 31, 2023 | 239.10M |
| September 30, 2023 | 230.10M |
| June 30, 2023 | 169.20M |
| March 31, 2023 | 138.10M |
| December 31, 2022 | 230.80M |
| September 30, 2022 | 168.90M |
| June 30, 2022 | 173.10M |
| March 31, 2022 | 151.20M |
| December 31, 2021 | 160.80M |
| September 30, 2021 | 190.10M |
| June 30, 2021 | 144.40M |
| March 31, 2021 | 88.70M |
| December 31, 2020 | 148.70M |
| September 30, 2020 | 118.60M |
| Date | Value |
|---|---|
| June 30, 2020 | 148.10M |
| March 31, 2020 | 57.10M |
| December 31, 2019 | 106.40M |
| September 30, 2019 | 108.10M |
| June 30, 2019 | 105.10M |
| March 31, 2019 | 47.60M |
| December 31, 2018 | 73.20M |
| September 30, 2018 | 88.40M |
| June 30, 2018 | 82.00M |
| March 31, 2018 | 45.00M |
| December 31, 2017 | 81.50M |
| September 30, 2017 | 75.80M |
| June 30, 2017 | 85.30M |
| March 31, 2017 | 20.70M |
| December 31, 2016 | 71.80M |
| September 30, 2016 | 68.40M |
| June 30, 2016 | 76.20M |
| March 31, 2016 | 3.00M |
| December 31, 2015 | 68.00M |
| September 30, 2015 | 68.80M |
| June 30, 2015 | 77.50M |
| March 31, 2015 | -1.90M |
| December 31, 2014 | 46.00M |
| September 30, 2014 | 63.90M |
| June 30, 2014 | 64.20M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Quarterly) Benchmarks
| Globus Medical, Inc. | 265.23M |
| Glaukos Corp. | 38.57M |
| The Cooper Cos., Inc. | 341.70M |
| Intuitive Surgical, Inc. | 1.224B |
| Becton, Dickinson & Co. | 1.458B |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | 78.90M |
| Cash from Financing (Quarterly) | -241.80M |
| Free Cash Flow | 453.40M |
| Free Cash Flow Per Share (Quarterly) | 2.124 |
| Free Cash Flow to Equity (Quarterly) | 153.00M |
| Free Cash Flow to Firm (Quarterly) | 153.30M |
| Free Cash Flow Yield | 1.64% |